tirzepatide body composition Greater lean-body-mass decline with than semaglutide in routine care, revealed by body-composition digital phenotyping Body Composition changes with semaglutide
Description
2020;192:E87591
Salt Lake City, UT Down 38 lbs in 5 months
Tirzepatide is a dual incretin receptor agonist, meaning it activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor
To prevent treatment interruption, contact your healthcare provider or pharmacist promptly to obtain a replacement pen
Compounding pharmacies can also prepare tirzepatide even when commercial versions are in limited supply, making treatment more accessible
Maintaining proper reconstitution and storage ensures you are getting the full dose you expect
